Abstract:
A method of treating a disease in which inhibiting of a proteasome is advantageous is provided. The method comprises administering to the subject a therapeutically effective amount of a compound which binds to a proteasome of a cell, the compound comprising a copper bound to a ligand, the ligand being configured such that upon binding to the proteasome, the copper interacts with cysteine 31 of a Beta2 subunit of the proteasome and further interacts with cysteine 118 of a Beta3 subunit of the proteasome, thereby treating the disease. Additional novel proteasome inhibitors are also provided as well as methods of identifying proteasome inhibitors.
Abstract:
Isolated polynucleotides are disclosed which increase the efficiency of gene expression in a heterologous cell. The polynucleotide sequences which encode polypeptides are adapted such that the average rate of translation of the first at least about 30 amino acids is slower by at least two fold than the average rate of translation of the remaining amino acids of the polypeptide.
Abstract:
An isolated polypeptide is disclosed comprising an amino acid sequence selected from the group consisting of SEQ ID NOs: 2773-5544 and 11089-11094, wherein the polypeptide has antimicrobial activity. Uses thereof for treating microbial infections are also disclosed.
Abstract translation:公开了分离的多肽,其包含选自SEQ ID NO:2773-5544和11089-11094的氨基酸序列,其中所述多肽具有抗微生物活性。 还公开了其用于治疗微生物感染的用途。
Abstract:
The present invention discloses a sensor device comprising a probe carrying a three-dimensional magnetic field sensor. The probe has a conical tip portion with an edge being configured as the three-dimensional magnetic field sensor. The sensor at the edge of the tip comprises at least three Josephson junctions, each junction being formed of a superconducting layer interrupted by a barrier. The barrier comprises a non-superconducting layer or a geometrical constriction. The conical tip portion of the probe forms a tapered three-dimensional structure having at least one arc-like part crossing the opening of the tip portion such that the apex has a closed-loop basis and a plurality of complimentary spaced-apart facets defined by the at least one arc, thereby enabling measurement of both in-plane and out-of-plane magnetic fields separately.
Abstract:
Methods and kits for diagnosing systemic lupus erythematosus (SLE) or scleroderma in a subject are provided. Particularly, the present invention relates to a specific antibody reactivity profile useful in diagnosing SLE or scleroderma in a subject.
Abstract:
A method of treating cancer is disclosed. The method comprises administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising an agent which induces a dissociation of the 26S proteasomal complex into a 20S component and a 19S component to thereby inhibit 26S proteasomal activity, wherein the pharmaceutical agent is devoid of a chemotherapeutic agent.
Abstract:
microRNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions are provided.
Abstract:
An imaging method and system are provided, being particularly useful for imaging a relatively wide field of regard on a relatively small detection surface with high spatial resolution. The method comprises: creating a segmented image of a field of regard in an effective object plane, said image being formed by an array of N image parts of the field of regard; and projecting a selected number M≧1 of patterns of structured light onto a detection surface, which is located in a plane conjugate to the effective object plane and has geometry and size substantially of the image part, each of the M patterns being formed by selected K light components of said N image parts concurrently projected onto the entire detection surface forming a superposition of the K image parts, thereby enabling reconstruction of the image of the field of regard from detected number M of patterns of the structured light.
Abstract:
The present invention provides semiconductor devices, particularly devices based on the Molecular Controlled Semiconductor Resistor (MOCSER), which are highly stable in aqueous solutions. The semiconductor devices of the invention may be used for the detection of various target molecules, e.g., proteins, peptides, carbohydrates and small molecules, in different solutions such as physiological solution, bodily fluids and bodily fluid-based solutions.
Abstract:
The present invention relates to peptides capable of inhibiting cellular and immune stress responses in a eukaryotic cell. The invention provides compositions and methods for the treatment of human degenerative diseases and inflammation, utilizing these peptides.